| Watson Pharmaceuticals, Inc. (Watson) is a specialty pharmaceutical company engaged in the development, manufacture, marketing, sale and distribution of brand and generic (off-patent) pharmaceutical products. The Company operates through three business segments: The Company operates through three business segments: Generic, Brand and Distribution. As of December 31, 2007, the Company marketed 150 generic pharmaceutical product families and 27 brand pharmaceutical product families through its Generic and Brand segments, respectively, and distributed approximately 8,000 stock-keeping units (SKUs) through its Distribution segment. The Company's operations are based predominantly in the United States and India, with its key commercial market being the United States. In July 2008, Watson and Mylan Inc. announced that Mylan Inc. has acquired Watson's 50% interest in the Somerset Pharmaceuticals, Inc. joint venture. |
